The effect of Lactobacillus plantarum 299V on the incidence of Clostridium difficile infection in high risk patients treated with antibiotics

Nutrients

Volumn 7, Issue 12, 2015, Pages 10179-10188

  Kujawa Szewieczek, Agata ^a   Adamczak, Marcin ^a   Kwiecień, Katarzyna ^a   Dudzicz, Sylwia ^a   Gazda, Magdalena ^a   Więcek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Clostridium difficile; Kidney and pancreas transplantation; Kidney transplantation; Lactobacillus plantarum 299v; Liver transplantation; Nephrology and transplantation ward

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; GLYCOPEPTIDE; LACTOBACILLUS PLANTARUM 299V; LINEZOLID; MACROLIDE; PROBIOTIC AGENT; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE INFECTION; DEMOGRAPHY; DISEASE SEVERITY; DRUG ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LACTOBACILLUS PLANTARUM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; AGED; CLOSTRIDIUM INFECTIONS; DRUG EFFECTS; INCIDENCE; PEPTOCLOSTRIDIUM DIFFICILE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; LACTOBACILLUS PLANTARUM; MALE; MIDDLE AGED; PROBIOTICS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84949571050     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7125526     Document Type: Article

References (37)

1. Barbut, F.; Petit, J. C. Epidemiology of Clostridium difficile-associated infections. Clin. Microbiol. Infect. 2001, 7, 405-410. [CrossRef] [PubMed].
2. Keven, K.; Basu, A.; Re, L.; Tan, H.; Marcos, A.; Fung, J. J.; Starzl, T. E.; Simmons, R. L. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl. Infect. Dis. 2004, 6, 10-14. [CrossRef] [PubMed].
3. Niemczyk, M.; Leszczýnski, P.; Wyzgał, J.; Paczek, L.; Krawczyk, M.; Luczak, M. Infections caused by Clostridium difficile in kidney or liver graft recipients. Ann. Transplant. 2005, 10, 70-74. [PubMed].
4. Khanna, S.; Pardi, D. S. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert. Rev. Gastroenterol. Hepatol. 2010, 4, 409-416. [CrossRef] [PubMed].
5. Noblett, S. E.; Welfare, M.; Seymore, K. The role of surgery in Clostridium difficile colitis. Br. Med. J. 2009, 338, 1563. [CrossRef] [PubMed].
6. Pépin, J.; Valiquette, L.; Alary, M. E.; Villemure, P.; Pelletier, A.; Forget, K.; Pepin, K.; Chouinard, D. Clostridium difficile associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 2004, 171, 466-472. [CrossRef] [PubMed].
7. Fakety, R.; McFarland, L. V.; Surowicz, C. M.; Greenberg, R. N.; Elmer, G. W.; Mulligan, M. E. Recurrent C. Recurrent Clostridium difficile diarrhoea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin. Infect. Dis. 1997, 24, 324-333. [CrossRef].
8. Olsen, M. A.; Yan, Y.; Reske, K. A.; Zilberberg, M. D.; Dubberke, E. R. Recurrent Clostridium difficile infection is associated with increased mortality. Clin. Microbiol. Infect. 2015, 21, 164-170. [CrossRef] [PubMed].
9. Albright, J. B.; Bonatti, H.; Mendez, J.; Kramer, D.; Stauffer, J.; Hinder, R.; Michel, J. A.; Dickson, R. C.; Huqhes, C.; Nquyen, J.; et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl. Int. 2007, 20, 856-866. [CrossRef] [PubMed].
10. Apaydin, S.; Altiparmak, M. R.; Saribas, S.; Ozturk, R. Prevalence of Clostridium difficile toxin in kidney transplant recipients. Scand. J. Infect. Dis. 1998, 30, 542. [PubMed].
11. Dubberke, E. R.; Riddle, D. J. Clostridium difficile in solid organ transplant recipients. Am. J. Transpl. 2009, 9, 35-40. [CrossRef] [PubMed].
12. Goldenberg, J. Z.; Ma, S. S.; Saxton, J. D.; Martzen, M. R.; Vandvik, P. O.; Thorlund, K.; Guyatt, G. H.; Johnston, B. C. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev. 2013, 31-35. [CrossRef].
13. Allen, S. J.; Wareham, K.; Wang, D.; Bradley, C.; Hutchings, H.; Harris, W.; Dhar, A.; Brown, H.; Foden, A.; Gravenor, M. B.; et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2013, 382, 1249-1257. [CrossRef].
14. Daneman, D. A probiotic trial: tipping the balance of evidence? Lancet 2013, 382, 1228-1230. [CrossRef].
15. Molin, G.; Jeppsson, B.; Ahrné, S.; Johansson, M. L.; Nobaek, S.; Ståhl, M.; Bengmark, S. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J. Appl. Bacteriol. 1993, 74, 314-323. [CrossRef] [PubMed].
16. Johansson, M. L.; Molin, G.; Jeppsson, B.; Nobaek, S.; Ahrné, S.; Bengmark, S. Administration of different Lactobacillus strains in fermented oatmeal soup: In vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl. Environ. Microbiol. 1993, 59, 15-20. [PubMed].
17. Ahrné, S.; Nobaek, S.; Jeppsson, B.; Adlerberth, I.; Wold, A.; Molin, G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 1998, 85, 88-94. [CrossRef] [PubMed].
18. Gross, G.; Snel, J.; Boekhorst, J.; Smits, M. A.; Kleerebezem, M. Biodiversity of mannose-specific adhesion in Lactobacillus plantarum revisited: Strain-specific domain composition of the mannose-adhesin. Benef. Microbes. 2010, 1, 61-66. [CrossRef] [PubMed].
19. Glenting, J.; Beck, H. C.; Vrang, A.; Riemann, H.; Ravn, P.; Hansen, A. M.; Antonsson, M.; Ahrné, S.; Israelsen, H.; Madsen, S. Anchorless surface associated glycolytic enzymes from Lactobacillus plantarum 299v bind to epithelial cells and extracellular matrix proteins. Microbiol. Res. 2013, 168, 245-253. [CrossRef] [PubMed].
20. Adawi, D.; Kasravi, F. B.; Molin, G.; Jeppsson, B. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model. Hepatology 1997, 25, 642-647. [CrossRef] [PubMed].
21. Osman, N.; Adawi, D.; Ahrne, S.; Jeppsson, B.; Molin, G. Probiotic strains of Lactobacillus and Bifidobacterium affect the translocation and intestinal load of Enterobacteriaceae differently after D-galactose-induced liver injury in rats. Microb. Ecol. Health Dis. 2005, 17, 40-46. [CrossRef].
22. Mangell, P.; Lennernäs, P.; Wang, M.; Olsson, C.; Ahrné, S.; Molin, G.; Thorlacius, H.; Jeppsson, B. Adhesive capability of L plantarum 299v is important for preventing bacterial translocation in endotoxaemic rats. APMIS 2006, 114, 611-618. [CrossRef] [PubMed].
23. Mangiante, G.; Colucci, G.; Canepari, P.; Bassi, C.; Nicoli, N.; Casaril, A.; Marinello, P.; Bengmark, S. Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Digest. Surg. 2001, 18, 47-50. [CrossRef].
24. McCracken, V. J.; Chun, T.; Baldeón, M. E.; Ahrné, S.; Molin, G.; Mackie, R. I.; Gaskins, H. R. TNF-β sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp. Biol. Med. 2002, 227, 665-670.
25. Jacobsen, C. N.; Rosenfeldt-Nielsen, V.; Hayford, A. E.; Moller, P. L.; Michaelsen, K. F.; Poerregaard, A.; Sandstróm, B.; Tvede, M.; Jakobsen, M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 1999, 65, 4949-4956. [PubMed].
26. Hiitt, P.; Shchepetova, I.; Loivukene, K.; Kullisaar, T.; Mikelsaar, M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero-and urpathogens. J. Appl. Microbiol. 2006, 100, 1324-1332. [CrossRef] [PubMed].
27. Mack, D. R.; Michail, S.; Wei, S.; McDougall, L.; Hollingsworth, M. A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276, 941-950.
28. Michail, S.; Abernathy, F. Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J. Pediatr. Gastroenterol. Nutr. 2002, 35, 350-355. [CrossRef] [PubMed].
29. Nobaek, S.; Johansson, M. L.; Molin, G.; Ahrné, S.; Jeppsson, B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol. 2000, 95, 1231-1238. [CrossRef] [PubMed].
30. Niedzielin, K.; Kordecki, H.; Birkenfeld, B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 2001, 13, 1143-1147. [CrossRef] [PubMed].
31. Lönnermark, E.; Friman, V.; Lappas, G.; Sandberg, T.; Berggren, A.; Adlerberth, I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J. Clin. Gastroenterol. 2010, 44, 106-112. [CrossRef] [PubMed].
32. Wullt, M.; Hagslätt, M. L.; Odenholt, I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: A double-blind, placebo-controlled trial. Scand. J. Infect. Dis. 2003, 35, 365-367. [CrossRef] [PubMed].
33. Klarin, B.; Wullt, M.; Palmquist, I.; Molin, G.; Larsson, A.; Jeppsson, B. Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiol. Scand. 2008, 52, 1096-1102. [CrossRef] [PubMed].
34. Wullt, M.; Johansson Hagslätt, M. L.; Odenholt, I.; Berggren, A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea. Dig. Dis. Sci. 2007, 52, 2082-2086. [CrossRef] [PubMed].
35. Debast, S. B.; Bauer, M. P.; Kuijper, E. J. European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 2014, 20, 1-26. [PubMed].
36. Johansson, M. L.; Nobaek, S.; Berggren, A.; Nyman, M.; Björck, I.; Ahrné, S.; Jeppsson, B.; Molin, G. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int. J. Food Microbiol. 1998, 42, 29-38. [CrossRef].
37. Mortensen, P. B.; Clausen, M. R. Short-chain fatty acids in the human colon: Relation to gastrointestinal health and disease. Scand. J. Gastroenterol. Suppl. 1996, 216, 132-148. [CrossRef] [PubMed].